PUFA supplements and type 2 diabetes in the elderly

Current Pharmaceutical Design

Volumn 15, Issue 36, 2009, Pages 4126-4134

  Abbatecola, A M ^a   Evans, W ^b   Paolisso, G ^c  

^a INRCA   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Aging; Cognitive decline; Disability; Insulin resistance; Polyunsaturated fatty acids; Type 2 diabetes

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; SAFFLOWER OIL;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEMENTIA; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MEGADOSE; DYSLIPIDEMIA; ELDERLY CARE; FAT INTAKE; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-3; HUMANS; INSULIN RESISTANCE;

EID: 71849116298     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789909782     Document Type: Review

References (106)

1. Evans WJ, Farrell PA. In: Jefferson JS, Cherrington AD, Eds. The Handbook of Physiology. Oxford: Oxford University Press 2001; pp. 969-999
2. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 1997; 5: 93-99 (Pubitemid 127702753)
3. Boden G. Fatty acids and insulin resistance. Diabetes Care 1996; 19: 394-395
4. Bodkin NL, Metzger BL, Hansen BC. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 1989; 256: E676-81.
5. Chavez AO, Lopez-Alvarenga JC, Tejero ME, Triplitt C, Bastarrachea RA, Sriwijitkamol A, et al. Physiological and molecular determinants of insulin action in the baboon. Diabetes 2008; 57: 899-908.
6. Barzilai N, Rossetti L. Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am J Physiol 1996; 270: E930-6. (Pubitemid 26298573)
7. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 1166-1173
8. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997; 30: 1144-1149 (Pubitemid 27476171)
9. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 1998; 101: 1353-1361 (Pubitemid 28166832)
10. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 1987; 36: 1341-1350 (Pubitemid 17163997)
11. Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 2001; 90: 2157-2165 (Pubitemid 32467407)
12. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332
13. Trayhurn P, Wood IS Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355 (Pubitemid 40277057)
14. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978
15. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 1998; 275: E294-9. (Pubitemid 28391809)
16. Hak AE, Pols HAP, Stehouwer CDA Meijer J, Kiliaan AJ, Hofman A, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam study. J Clin Endocrinol Metab 2001; 86: 4398-4405 (Pubitemid 32848565)
17. Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, et al. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 2005; 28: 2007-2012 (Pubitemid 41060976)
18. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000; 83: S91-96. (Pubitemid 30319088)
19. Mayer EJ, Newman B, Quesenberry CP, Jr., Selby JV. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 1993; 16: 1459-1469 (Pubitemid 23312534)
20. Tataranni PA, Ravussin E. Effect of fat intake on energy balance. Ann N Y Acad Sci 1997; 819: 37-43. (Pubitemid 27303287)
21. Wright JD, Kennedy-Stephenson J, Wang CY, McDowell MA, Johnson CL. Trends in intake of energy and macronutrients - United States, 1971 - 2000. MMWR Morb Mortal Wkly Rep 2004; 53: 80-82
22. Hays NP, Starling RD, Liu X, Sullivan DH, Trappe TA, Fluckey JD, et al. Effects of an ad libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men and women: a randomized controlled trial. Arch Intern Med 2004; 164: 210-217 (Pubitemid 38140409)
23. Hays NP, Starling RD, Sullivan DH, Fluckey JD, Coker RH, Williams RH, et al. Effects of an ad libitum, high carbohydrate diet and aerobic exercise training on insulin action and muscle metabolism in older men and women. J Gerontol A Biol Sci Med Sci 2006; 61: 299-304.
24. Jequier E. Body weight regulation in humans: the importance of nutrient balance. Int Union Phyiol Sci/Am Phiol Soc 1993; 8: 273-276 (Pubitemid 24754619)
25. Polonsky KS. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 1995; 44: 705-717
26. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-870
27. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498-2502 (Pubitemid 28145970)
28. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997; 100: 398-403 (Pubitemid 27349087)
29. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop T2D. Diabetes 2003; 52: 2461-2474 (Pubitemid 37210533)
30. Xiao C, Giacca A, Carpentier A, Lewis GF. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 2006; 49: 1371-1379
31. Khan SA, Vanden Heuvel JP. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids. J Nutr Biochem 2003; 14: 554-567
32. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-656 (Pubitemid 23132798)
33. Paolisso G, D'Amore A, Balbi V, Volpe C, Galzerano D, Giugliano D, et al. F. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994; 266: E261-8. (Pubitemid 24099280)
34. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996; 271: 13018-13022 (Pubitemid 26175877)
35. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR. Crosstalk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996; 93: 12490-12495 (Pubitemid 26367171)
36. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997; 100: 2158-2169 (Pubitemid 27500137)
37. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806 (Pubitemid 34000783)
38. Frangioudakis G, Ye JM, Cooney GJ. Both saturated and n-6 polyunsaturated fat diets reduce phosphorylation of insulin receptor substrate-1 and protein kinase B in muscle during the initial stages of in vivo insulin stimulation. Endocrinology 2005; 146: 5596-5603 (Pubitemid 41653076)
39. Taouis M, Dagou C, Ster C, Durand G, Pinault M, Delarue J. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am J Physiol Endocrinol Metab 2002; 282: E664-71. (Pubitemid 34654784)
40. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinaseac tivity in muscle. J Biol Chem 2002; 277: 50230-50236 (Pubitemid 36042170)
41. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885-888
42. Slater SJ, Kelly MB, Yeager MD, Larkin J, Ho C, Stubbs CD. Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins.Lipids 1996; 31: S189-92.
43. Field CJ, Ryan EA, Thomson AB, Clandinin MT. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 1990; 265: 11143-11150 (Pubitemid 20200116)
44. Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp Clin Endocrinol Diabetes 2003; 111: 246-250 (Pubitemid 37040104)
45. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238-244 (Pubitemid 23035309)
46. Thomassen MS, Christiansen EN, Norum KR. Characterization of the stimulatory effect of high-fat diets on peroxisomal betaoxidation in rat liver. Biochem J 1982; 206: 195-202.
47. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R.Suppression by diets rich in fish oil of very low density lipoprotein production in man.J Clin Invest 1984; 74: 82-89
48. Galgani JE, Uauy RD, Aguirre CA, Díaz EO. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 2008; 8: 1-9.
49. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, et al. KANWU Study. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44: 312-319
50. Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002; 45: 369-377 (Pubitemid 34267359)
51. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006; 84: 540-550 (Pubitemid 44713403)
52. Borkman M, Chisholm DJ, Furler SM, Storlien LH, Kraegen EW, Simons LA, et al. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 1989; 38: 1314-1319 (Pubitemid 19247429)
53. Vessby B, Karlström B, Boberg M, Lithell H, Berne C. Polyunsaturated fatty acids may impair blood glucose control in type 2 diabetic patients. Diabet Med 1992; 9: 126-133
54. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998; 21: 494-500.
55. Sirtori CR, Crepaldi G, Manzato E, Mancini M, Rivellese A, Paoletti R, et al. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 1998; 137: 419-427 (Pubitemid 28215888)
56. Arner P. Insulin resistance in T2D: role of fatty acids. Diabetes Metab Res Rev 2002; 18: S5-9. (Pubitemid 34467308)
57. Marshall JA, Hoag S, Shetterly S, Hamman RF. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994; 17: 50-56
58. Raheja BS, Sadikot SM, Phatak RB, Rao MB. Significance of the N-6/N-3 ratio for insulin action in diabetes. Ann N Y Acad Sci 1993; 683: 258-271 (Pubitemid 23236676)
59. Rosholt MN, King PA, Horton ES. High-fat diet reduces glucose transporter responses to both insulin and exercise. Am J Physiol 1994; 266: R95-101
60. Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 2002; 283: E12-9. (Pubitemid 34686662)
61. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994 8; 91: 10878-10882 (Pubitemid 24985069)
62. Kromann N, Green A Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980; 208: 401-406
63. Bjerregaard P, Mulvad G, Pedersen HS. Cardiovascular risk factors in Inuit of Greenland. Int J Epidemiol 1997; 26: 1182-1190 (Pubitemid 28010435)
64. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2008; CD003205.
65. De Caterina R, Madonna R, Bertolotto A, Schmidt EB. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 2007; 30: 1012-1026 (Pubitemid 46556605)
66. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003; 31: 1066-1069
67. Harris WS, Lu G, Rambjør GS, Wålen AI, Ontko JA, Cheng Q, et al. Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 1997; 66: 254-260 (Pubitemid 27360322)
68. De Caterina R, Madonna R. Nutrients and gene expression. World Rev Nutr Diet 2004; 93: 99-133.
69. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Best JD, et al. Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. Diabetes Care 2003; 26: 253. (Pubitemid 36929035)
70. Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Metaanalysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with T2D. Diabetologia 2007; 50: 1593-1602 (Pubitemid 47036644)
71. Zhou XR, Sun CH, Liu JR, Zhao D. Dietary conjugated linoleic acid increases PPARgamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res 2008; 18: 361-368
72. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res 2002; 10: 518-525 (Pubitemid 135686644)
73. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavourably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care 2001; 24: 366-370 (Pubitemid 32119140)
74. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002; 441: 1-14. (Pubitemid 34465684)
75. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA 2000; 283: 1615-1617
76. Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atherocler Rep 2004; 6: 261-266 (Pubitemid 39359464)
77. Farris W, Manourian S, Chang Y, Lindsley L, Eckman E, Frosch M, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100: 4162-4167 (Pubitemid 36418174)
78. Biessels GJ, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33: 1041-1044
79. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's diesease. Nature 1996; 382: 685-691 (Pubitemid 26282167)
80. Petersen RC. Mild Cognitive Impairment: Aging to Alzheimer's Disease. New York, NY: Oxford University Press 2003.
81. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42: 776-782 (Pubitemid 27481550)
82. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007; 62: 1120-1126 (Pubitemid 47599423)
83. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940-946 (Pubitemid 36858352)
84. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305-1312 (Pubitemid 32064179)
85. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003; 89: 483-489 (Pubitemid 36582118)
86. Luchsinger JA, Reitz C, Patel B, Tang M, Manly J, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570-575 (Pubitemid 46588347)
87. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005; 13: 950-958 (Pubitemid 46638661)
88. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008; 70: 440-448
89. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.Arch Neurol 2006; 63: 1402-1408
90. Horrocks LA, Farooqui AA. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 361-372
91. Corey EJ, Shih C, Cashman J.R Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis, Proc. Natl. Acad. Sci. USA 1983; 80: 3581-3584
92. James MJ, Gibson RA, Cleland LG, Dietary polyunsaturated fatty acids and inflammatory mediator production, Am. J. Clin. Nutr 2000; 71: 343S-8.
93. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M85-94. (Pubitemid 24100267)
94. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-1685
95. Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci 1995; 50: 5-8.
96. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J 2001; 15: 1169-1180
97. Ayre KJ, Hulbert AJ. Effects of changes in dietary fatty acids on isolated skeletal muscle functions in rats. J Appl Physiol 1996; 80: 464-471
98. LIFE Study Investigators, Pahor M, Blair SN, Espeland M, Fielding R, Gill TM, Guralnik JM, et al. Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci 2006; 61: 1157-1165 (Pubitemid 46034466)
99. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59: 242-248 (Pubitemid 38375337)
100. Semba RD, Varadhan R, Bartali B, Ferrucci L, Ricks MO, Blaum C, et al. Low serum carotenoids and development of severe walking disability among older women living in the community: the women's health and aging study I. Age Ageing 2007; 36: 62-67 (Pubitemid 47072036)
101. Cesari M, Pahor M, Bartali B, Cherubini A, Penninx BW, Williams GR, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr 2004; 79: 289-294 (Pubitemid 41095983)
102. Wigmore SJ, Barber MD, Ross JA. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000; 36: 177-184.
103. Moses AWG, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004; 90: 996-1002. (Pubitemid 38495818)
104. Barsotti A, Giannoni A, Di Napoli P, Emdin M. Energy metabolism in the normal and in the diabetic heart. Curr Pharm Des 2009; 15(8): 836-840
105. Tousoulis D, Kampoli AM, Papageorgiou N, Papaoikonomou S, Antoniades C, Stefanadis C. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches. Curr Pharm Des 2009; 15(17): 2037-2048
106. Vitale C, Collin P. Optimization of cardiac metabolism in diabetes mellitus. Curr Pharm Des 2008; 14(25): 2537-2550